Gottlieb vows to uphold FDA's 'gold standard'
from By Dr. Abimbola Farinde
Ever since President Donald Trump was inaugurated in January, he has pledged to cut burdensome regulations on businesses and industry. When it comes to the pharmaceutical industry, Trump vowed to "slash the restraints" on drug development. But some within the industry are skeptical about the safety of this approach, which has brought controversy to Trump's nominee to head the FDA, Scott Gottlieb, who recently spoke before the Senate during his confirmation hearing.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063